Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys

Adv Neurol. 1993;60:113-8.
No abstract available

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology*
  • Animals
  • Antiparkinson Agents / pharmacology*
  • Brain Mapping
  • Carbidopa / pharmacology
  • Corpus Striatum / drug effects
  • Corpus Striatum / physiopathology
  • Dopamine Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects
  • Down-Regulation / physiology
  • Drug Combinations
  • Dyskinesia, Drug-Induced / physiopathology*
  • Female
  • Levodopa / pharmacology
  • Locomotion / drug effects
  • Locomotion / physiology
  • Macaca fascicularis
  • Parkinson Disease, Secondary / chemically induced*
  • Parkinson Disease, Secondary / physiopathology
  • Psychomotor Performance / drug effects
  • Psychomotor Performance / physiology
  • Receptors, Dopamine D1 / drug effects*
  • Receptors, Dopamine D1 / physiology
  • Receptors, Dopamine D2 / drug effects*
  • Receptors, Dopamine D2 / physiology

Substances

  • Antiparkinson Agents
  • Dopamine Agents
  • Drug Combinations
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • carbidopa, levodopa drug combination
  • Levodopa
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Carbidopa